144 related articles for article (PubMed ID: 10209666)
1. Genetic predisposition to gastric cancer.
Bevan S; Houlston RS
QJM; 1999 Jan; 92(1):5-10. PubMed ID: 10209666
[No Abstract] [Full Text] [Related]
2. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications of E-cadherin associated hereditary diffuse gastric cancer.
Fitzgerald RC; Caldas C
Gut; 2004 Jun; 53(6):775-8. PubMed ID: 15138199
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between CDH1 C-160A genetic polymorphism and gastric cancer risk among Asian population.
Pan F; Tian J; Zhang Y; Pan Y
DNA Cell Biol; 2012 Mar; 31(3):275-6; author reply 277-9. PubMed ID: 22142022
[No Abstract] [Full Text] [Related]
5. Genetic mutations identified for hereditary diffuse gastric cancer.
Peek R; Reddy KR
Gastroenterology; 2007 Aug; 133(2):379-80. PubMed ID: 17681152
[No Abstract] [Full Text] [Related]
6. CDH1 C-160A polymorphism and gastric cancer risk: evidence needed for clarification.
Zhang T; Zhao Z; Cao X; Yao Q
DNA Cell Biol; 2012 Mar; 31(3):272; author reply 273-4. PubMed ID: 22066580
[No Abstract] [Full Text] [Related]
7. Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients.
Keller G; Vogelsang H; Becker I; Plaschke S; Ott K; Suriano G; Mateus AR; Seruca R; Biedermann K; Huntsman D; Döring C; Holinski-Feder E; Neutzling A; Siewert JR; Höfler H
J Med Genet; 2004 Jun; 41(6):e89. PubMed ID: 15173255
[No Abstract] [Full Text] [Related]
8. Genetics of gastric cancer: clinical implications.
Scarpa A; Moore PS
Suppl Tumori; 2003; 2(5):S10-3. PubMed ID: 12914381
[No Abstract] [Full Text] [Related]
9. Meta-analysis: tumour invasion-related genetic polymorphisms and gastric cancer susceptibility.
Gao L; Nieters A; Brenner H
Aliment Pharmacol Ther; 2008 Sep; 28(5):565-73. PubMed ID: 18544073
[TBL] [Abstract][Full Text] [Related]
10. Absence of microsatellite instability and germline mutations of E-cadherin, APC and p53 genes in Japanese familial gastric cancer.
Kusano M; Kakiuchi H; Mihara M; Itoh F; Adachi Y; Ohara M; Hosokawa M; Imai K
Tumour Biol; 2001; 22(4):262-8. PubMed ID: 11399952
[TBL] [Abstract][Full Text] [Related]
11. Hereditary diffuse gastric cancer: lifesaving total gastrectomy for CDH1 mutation carriers.
Lynch HT; Lynch JF
J Med Genet; 2010 Jul; 47(7):433-5. PubMed ID: 20591881
[No Abstract] [Full Text] [Related]
12. Genes and gastric cancer.
Kyrlagkitsis I; Karamanolis DG
Hepatogastroenterology; 2004; 51(55):320-7. PubMed ID: 15011894
[TBL] [Abstract][Full Text] [Related]
13. [Familial aggregation of gastric cancer].
Sugimura H
Gan To Kagaku Ryoho; 2008 Apr; 35(4):551-6. PubMed ID: 18408421
[TBL] [Abstract][Full Text] [Related]
14. [Familial gastric cancer].
Arai M; Miki Y; Muto T; Kato Y
Nihon Rinsho; 2001 Apr; 59 Suppl 4():251-6. PubMed ID: 11424388
[No Abstract] [Full Text] [Related]
15. CDH1 -160C>A gene polymorphism is an ethnicity-dependent risk factor for gastric cancer.
Pan F; Tian J; Zhang Y; Pan YY
Cytokine; 2012 Jul; 59(1):20-1. PubMed ID: 22575615
[No Abstract] [Full Text] [Related]
16. Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer.
Xie ZM; Li LS; Laquet C; Penault-Llorca F; Uhrhammer N; Xie XM; Bignon YJ
Cancer; 2011 Jul; 117(14):3112-7. PubMed ID: 21271559
[TBL] [Abstract][Full Text] [Related]
17. [Molecular genetics study of hereditary predisposition to diffuse gastric cancer in Russian patients].
Tsukanov AC; Shelygin IuA; Kashnikov VN; Frolov SA; Liubchenko LN; Shubin VP; Karpukhin AV; Muzaffarova TA; Pospekhova NI
Vopr Onkol; 2013; 59(5):580-4. PubMed ID: 24260884
[TBL] [Abstract][Full Text] [Related]
18. Review article: Pathogenesis of sporadic and familial gastric cancer--implications for clinical management and cancer prevention.
Ebert MP; Malfertheiner P
Aliment Pharmacol Ther; 2002 Jun; 16(6):1059-66. PubMed ID: 12030946
[TBL] [Abstract][Full Text] [Related]
19. Hereditary aspects of gastric cancer.
Keller G
Pathologica; 2002 Oct; 94(5):229-33. PubMed ID: 12417969
[TBL] [Abstract][Full Text] [Related]
20. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
Brooks-Wilson AR; Kaurah P; Suriano G; Leach S; Senz J; Grehan N; Butterfield YS; Jeyes J; Schinas J; Bacani J; Kelsey M; Ferreira P; MacGillivray B; MacLeod P; Micek M; Ford J; Foulkes W; Australie K; Greenberg C; LaPointe M; Gilpin C; Nikkel S; Gilchrist D; Hughes R; Jackson CE; Monaghan KG; Oliveira MJ; Seruca R; Gallinger S; Caldas C; Huntsman D
J Med Genet; 2004 Jul; 41(7):508-17. PubMed ID: 15235021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
